Positive exercise test and normal exercise myocardial perfusion SPECT. Clinical significance;Ergometría positiva y SPECT de perfusión miocárdica normal. Significado clínico

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 3, 2005, Pages 174-184

  Ruiz Solis S ^a   Montero Gaspar, M ^a   Garcia Vicente A M ^a   Rodado Marina, S ^a   Poblete Garcia V M ^a   Cortes Romero M ^a   Talavera Rubio, P ^a   Soriano Castrejon A ^a  

^a Hospital Alarcos   (Spain)

Author keywords

Coronary artery disease; Exercise test; Hypertensive cardiomyopathy; Normal myocardial perfusion study; Single photon emission computed tomography

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME X; THORAX PAIN; VALVULAR HEART DISEASE; VALVULOPATHY;

EID: 20544473550     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13073788     Document Type: Article

References (48)

1. Logan SE. On the fluid mechanics of human coronary artery stenosis. IEEE Trans Biomed Eng. 1975;22:327-34.
2. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/ exercise/dirIndex.htm.
3. Marcus ML, Wilson RF, White CW. Methods of measurement of myocardial blood flow in patients: a critical review. Circulation. 1987;76:245-53.
4. Farkoh ME, Smars PA, Reeder GS, Zinsmeister AR, Evans RW, Meloy TD, et al. A clinical trial of a chest-pain observation unit for patients with unstable angina. N Engl J Med. 1998;339: 1882-8.
5. Arós F, Loma-Osorio A. Diagnóstico de la angina inestable en el servicio de urgencias. Valor y limitaciones de la clinica, el electrocardiograma y las pruebas complementarias. Rev Esp Cardiol. 1999;52 Supl 1:39-45.
6. Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). 2003. American College of Cardiology Web site. Available at: http://www.acc.org/ clinical/guidelines/radio/rni_fulltext.pdf.
7. Boyne TS, Koplan BA, Parsons WJ, Smith WH, Watson DD, Beller GA. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol. 1997;79:270-4.
8. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol. 1998;32:57-62.
9. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation. 1991;83:363-81.
10. Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 1999;100:2140-5.
11. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-8.
12. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation. 1995;91:54-65.
13. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol. 2004;43: 209-12.
14. Poornima IG, Miller TD, Christian TF, Hodge DO, Bailey KR, Gibbons RJ. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol. 2004;43: 194-9.
15. Lee DS, Jang MJ, Cheon GJ, Chung JK, Lee MC. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results. J Nucl Cardiol. 2002;9:515-22.
16. Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m-sestamibi cardiac imaging. J Nucl Med. 1994; 35:554-7.
17. Soman P, Parsons A, Lahiri N, Lahiri A. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol. 1999;6:252-6.
18. Groutars RG, Verzijlbergen JF, Muller AJ, Ascoop CA, Tiel-van Buul MM, Zwinderman AH, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol. 2000;7:333-41.
19. Elhendy A, Schinkel A, Bax JJ, van Domburg RT, Poldermans D. Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study. J Nucl Cardiol. 2003;10:261-6.
20. Abdel Fattah A, Kamal AM, Pancholy S, Ghods M, Russell J, Cassel D, et al. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol. 1994;74:769-71.
21. Pavin D, Delonca J, Siegenthaler M, Doat M, Rutishauser W, Righetti A. Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography. Eur Heart J. 1997;18:69-77.
22. Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m) Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,278 patients. J Nucl Med. 2003;44:134-9.
23. Erraturn in: J Nucl Med. 2003;44:648.
24. Brown KA, Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognosis value of a normal exercise myocardial perfusion imaging. J Nucl Med. 1993;34: 1467-71.
25. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol. 1979;44:999-1006.
26. Opherk D, Mall G, Zebe H, Schwartz F, Weihe E, Manthey J, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation. 1984;69:1-7.
27. Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, et al. Angina due to coronary microvasculature disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 1988;319:1302-7.
28. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant ML. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol. 1990;15:43-51.
29. Pichard AD, Gorlin R, Smith H, Ambrose J, Meller J. Coronary flow studies in patients with left ventricular hypertrophy of the hypertensive type. Am J Cardiol. 1981;47:547-54.
30. Marcus ML, Koyanagi S, Harrison DG, Doty DB, Hiratzka LF, Eastham CL. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med. 1983; 75:62-6.
31. Romero-Farina G, Candell-Riera J, Pereztol-Valdes O, Aguade-Bruix S, Castell-Conesa J, Armadans L, et al. Myocardial SPET in hypertrophic cardiomyopathy. Rev Esp Cardiol. 2000;53: 1589-95.
32. Cecil MP, Pilcher WC, Eisner RL, Chu TH, Merlino JD, Patterson RE. Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy. Am J Cardiol. 1994;74:43-6.
33. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431-8.
34. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88:993-1003.
35. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87:86-93.
36. Ambrosi P, Bruneau P, Faugere G, Habib G, Poggi L, Luccioni R, et al. Prognostic value of thallium-201 myocardial scintigraphy in patients with hypertension, suspected of coronary disease. Ann Cardiol Angeiol (París). 1993;42:479-83.
37. Patel D, Baman TS, Beller GA. Comparison of the predictive value of exercise-induced ST depression versus exercise technetium-99m sestamibi single-photon emission computed tomographic imaging for detection of coronary artery disease in patients with left ventricular hypertrophy. Am J Cardiol. 2004;93:333-6.
38. Ozkan M, Kaymaz C, Dinckal H, Kirma C, Ozdemir N, Akdemir I, et al. Single-photon emission computed tomographic myocardial perfusion imaging in patients with mitral valve prolapse. Am J Cardiol. 2000;85:516-8.
39. Coma-Canella I, Martinez-Caro D, Cosin-Sales J, Fernandez-Jarne E, García-Velloso MJ, Giménez M. Clandestine ischemia in patients with vasospastic angina. Coron Artery Dis. 2000;11: 383-90.
40. Sueda S, Mineoi K, Kondou T, Yano K, Ochi T, Ochi N, et al. A case of variant angina pectoris with similar findings on both rest and matched exercise thallium-201 studies. Jpn Circ J. 1998;62:785-7.
41. Cannon RO, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338-43.
42. Bottcher M, Botker HE, Sonne H, Nielsen TT, Czernin J. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. Circulation. 1999;99:1795-801.
43. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:796-804.
44. Yamada M, Elliott PM, Kaski JC, Prasad K, Gane JN, Lowe CM, et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. Eur Heart J. 1998;19:500-7.
45. Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long-term additive prognostic value of Thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients. Study in 1137 patients with 6-year follow-up. Circulation. 1999;100:1521-7.
46. Del Val Gomez M, Gallardo FG, Salazar ML, Terol I. Valor pronostico de los estudios de perfusión miocárdica con T1-201 normal en pacientes con ergometria positiva. Rev Esp Cardiol. 2002;55:991-4.
47. He ZX, Dakik HA, Vaduganathan P, Qureshi U, Mahmarian JJ, Verani MS. Clinical and angiographyc significance of a normal thallium-201 tomographyc study in patients with a strongly positive exercise electrocardiogram. Am J Cardiol. 1996;78:638-41.
48. Candell-Riera J, Fernández C, Escudero F, De Léon G, Aguadé-Bruix S, Castell-Conesa J. Prevalence and angiographic significance of normal myocardial perfusion SPECT with positive exercise electrocardiogram. Rev Esp Cardiol. 2004;57:894-7.